Folusho Adeosun: Raising Fetal Hemoglobin as a Powerful Protective Shield in Sickle Cell Disease
Folusho Adeosun, Founder and CEO at Mo’sho Adeosun Health Initiative, shared a post on LinkedIn:
“Raising Fetal Hemoglobin.
Raising fetal hemoglobin is one of the most powerful protective shields a sickle cell warrior can have.
Yet many warriors living with SCD still do not know what fetal hemoglobin is, why it matters, or how life-changing it can be.
Fetal hemoglobin (HbF) is the type of hemoglobin we all had before birth.
Unlike sickle hemoglobin(HbS), it does not sickle.
It keeps red blood cells round, flexible, and able to move smoothly through blood vessels.
When fetal hemoglobin levels increase, something powerful happens. Pain crises can reduce, hospital visits will become less frequent and blood flow improves.
For many warriors, medications like hydroxyurea work by helping the body produce more fetal hemoglobin.
While nutrition cannot directly raise HbF like medication, good nutrition supports red blood cell production.
Important nutrients that help include:
- Folate (Vitamin B9) – supports RBC formation
- Vitamin B12
- Zinc
- Vitamin D
- Omega-3 fatty acids
These help optimize blood health but do not replace HbF-stimulating therapy.
This is why patient education matters.
A warrior who understands their blood is a warrior who knows the care their body deserves.
Because sometimes the difference between surviving and thriving with SCD begins with understanding what is flowing through your veins.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy